Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Hold
900
﹤0.01% 373
2026
Q1
$296K Sell
900
-4,135
-82% -$1.48M ﹤0.01% 356
2025
Q4
$1.77M Buy
5,035
+1,905
+61% +$694K 0.02% 220
2025
Q3
$1.16M Buy
3,130
+270
+9% +$104K 0.02% 220
2025
Q2
$1.13M Sell
2,860
-1,531
-35% -$573K 0.03% 212
2025
Q1
$1.63M Buy
4,391
+1,151
+36% +$438K 0.04% 191
2024
Q4
$1.17M Sell
3,240
-1,576
-33% -$584K 0.03% 212
2024
Q3
$1.74M Buy
4,816
+4,226
+716% +$1.46M 0.05% 178
2024
Q2
$201K Sell
590
-1,514
-72% -$513K 0.01% 325
2024
Q1
$753K Buy
+2,104
New +$708K 0.02% 241

Other funds holding SYK

Allianz's SYK Position: Q2 2026 in Review

Allianz held its Stryker (SYK) position steady in Q2 2026 at 900 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #373.

Allianz first reported a position in SYK in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.77M in Q4 2025. 2,257 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Allianz held 900 shares of Stryker worth $283K as of Q2 2026.
  • Allianz left its Stryker share count unchanged in Q2 2026.
  • Stryker made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #373 holding.
  • Allianz first reported a position in Stryker in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Stryker position peaked at $1.77M in Q4 2025.
  • 2,257 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.